Summit Therapeutics (SMMT) Times Interest Earned (2024)

Summit Therapeutics (SMMT) reported Times Interest Earned of -$7290.4 for Q4 2024, down 30546.39% quarter-over-quarter from -$23.79 in Q3 2024.

Summit Therapeutics (SMMT) Times Interest Earned (2024) Analysis & Trends

Summit Therapeutics has reported Times Interest Earned for 1 years, with the latest figure at -$7290.4 in Q4 2024.

For the quarter ending Q4 2024, Times Interest Earned changed N/A year-over-year to -$7290.4; the trailing twelve-month figure through Dec 2024 stood at -$26.02 (changed N/A YoY), and the FY2024 full-year result was -$26.02, up 29.75% from the prior year.
Times Interest Earned for Q4 2024 stood at -$7290.4, down from -$23.79 in the prior quarter.
The five-year high for Times Interest Earned was -$13.58 in Q1 2024, with the low at -$7290.4 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	3.58
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-258.33
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	11.50
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	547.67
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	11.79
10	Summit Therapeutics	10.09 Bn	9.99 Bn	-	-

Download Data